| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts Lancet 386 (9988), 31-45, 2015 | 1138 | 2015 |
| First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children RTS, S Clinical Trials Partnership New England Journal of Medicine 365 (20), 1863-1875, 2011 | 1021 | 2011 |
| A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants TRCT Partnership N Engl J Med 367, 2284-2295, 2012 | 900* | 2012 |
| Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated … A Salanti, T Staalsoe, T Lavstsen, ATR Jensen, MPK Sowa, DE Arnot, ... Molecular microbiology 49 (1), 179-191, 2003 | 853 | 2003 |
| Evidence for the involvement of VAR2CSA in pregnancy-associated malaria A Salanti, M Dahlbäck, L Turner, MA Nielsen, L Barfod, P Magistrado, ... The Journal of experimental medicine 200 (9), 1197-1203, 2004 | 705 | 2004 |
| Severe malaria is associated with parasite binding to endothelial protein C receptor L Turner, T Lavstsen, SS Berger, CW Wang, JEV Petersen, M Avril, ... Nature 498 (7455), 502-505, 2013 | 666 | 2013 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 476 | 2015 |
| Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites TRCT Partnership PLOS Medicine 11 (DOI: 10.1371/journal.pmed.1001685), e1001685, 2014 | 467 | 2014 |
| Plasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer TS Rask, DA Hansen, TG Theander, A Gorm Pedersen, T Lavstsen PLoS computational biology 6 (9), e1000933, 2010 | 445 | 2010 |
| Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions T Lavstsen, A Salanti, ATR Jensen, DE Arnot, TG Theander Malaria journal 2, 1-14, 2003 | 428 | 2003 |
| Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes ATR Jensen, P Magistrado, S Sharp, L Joergensen, T Lavstsen, ... Journal of Experimental Medicine 199 (9), 1179-1190, 2004 | 381 | 2004 |
| Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block … CH Ricke, T Staalsoe, K Koram, BD Akanmori, EM Riley, TG Theander, ... The Journal of immunology 165 (6), 3309-3316, 2000 | 378 | 2000 |
| Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection M Chen, TG Theander, SB Christensen, L Hviid, LIN Zhai, A Kharazmi Antimicrobial agents and chemotherapy 38 (7), 1470-1475, 1994 | 369 | 1994 |
| Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children T Lavstsen, L Turner, F Saguti, P Magistrado, TS Rask, JS Jespersen, ... Proceedings of the National Academy of Sciences 109 (26), E1791-E1800, 2012 | 322 | 2012 |
| Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania M Chen, SB Christensen, J Blom, E Lemmich, L Nadelmann, K Fich, ... Antimicrobial agents and chemotherapy 37 (12), 2550-2556, 1993 | 297 | 1993 |
| PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum L Jiang, J Mu, Q Zhang, T Ni, P Srinivasan, K Rayavara, W Yang, L Turner, ... Nature 499 (7457), 223-227, 2013 | 287 | 2013 |
| Inhibition of Fumarate Reductase inLeishmania major and L. donovani by Chalcones M Chen, L Zhai, SB Christensen, TG Theander, A Kharazmi Antimicrobial agents and chemotherapy 45 (7), 2023-2029, 2001 | 272 | 2001 |
| The antileishmanial activity of novel oxygenated chalcones and their mechanism of action L Zhai, M Chen, J Blom, TG Theander, SB Christensen, A Kharazmi Journal of antimicrobial chemotherapy 43 (6), 793-803, 1999 | 263 | 1999 |
| Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity MA Nielsen, T Staalsoe, JAL Kurtzhals, BQ Goka, D Dodoo, M Alifrangis, ... The Journal of Immunology 168 (7), 3444-3450, 2002 | 254 | 2002 |
| Differential Expression of var Gene Groups Is Associated with Morbidity Caused by Plasmodium falciparum Infection in Tanzanian Children M Rottmann, T Lavstsen, JP Mugasa, M Kaestli, ATR Jensen, D Müller, ... Infection and immunity 74 (7), 3904-3911, 2006 | 251 | 2006 |
Lars HviidUniversity of Copenhagen - Københavns UniversitetPreverjeni e-poštni naslov na sund.ku.dk
